Christina Xu

Christina Xu's work experience begins with a role as a Research Assistant at the University of California, San Diego in 2009. Christina then worked as a Research Assistant at the Sanford-Burnham Medical Research Institute in 2010 and as a Research Assistant at the Salk Institute for Biological Studies in 2011.

In 2012, Christina joined Cornell University as an Undergraduate Research Assistant, where they investigated the impact of amino acid substitution in Hsp70 BiP. Christina continued at Cornell University until 2014.

In 2015, Christina became a Research Associate at MabVax Therapeutics, Inc., where they contributed to antibody research and development, including the generation of stable cell lines and molecular cloning. Christina left the company in 2015.

From 2016 to 2017, Christina worked as a Research Associate at Proteostasis Therapeutics, Inc. During their tenure, they played a crucial role in executing in-house biology work, performing screening assays, and optimizing protein quantification assays.

In 2018, Christina joined Foghorn Therapeutics, Inc. as a Scientist. Christina held several roles within the company, including Senior Research Associate, Principal Research Associate, and Scientist. Christina'sresponsibilities included conducting research and performing scientific experiments.

Christina then worked at Zentalis Pharmaceuticals as an Associate Scientist from 2021 to 2022. Christina recently started a new position as a Scientist at Neomorph, Inc. in 2022.

Christina Xu pursued their education in a chronological manner. In 2011, they completed their high school education at La Jolla High School. Afterwards, from 2011 to 2014, they attended Cornell University where they earned their Bachelor's Degree in Biochemistry and Molecular Biology. Finally, from 2015 to 2017, Christina enrolled in the Boston University School of Medicine where they obtained their Master of Science (MS) degree in Medical Sciences.